Delivery Order 75N94024D00003-75N98026F00001
Award Date 4/21/26
Potential Completion Date 10/30/26
Potential Value $39K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Tonawanda, NY 14150, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Diabetes and Digestive and Kidney Diseases issued a $54,487.44 delivery order to Pine Pharmaceuticals LLC on September 30, 2024, under a total small business set-aside, for metabolic isotopes to support research studies conducted by various HHS agencies. The order is placed against Pine Pharmaceuticals' $7.27 million single-award indefinite delivery contract with NIDDK, which extends through September 29, 2029. Place of performance is Tonawanda, NY. Pine Pharmaceuticals...
- This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The $12,580.80 contract is for the acquisition of intravenous stable isotopes, which are specialized pharmaceutical compounds used in metabolic and clinical research studies. Pine Pharmaceuticals is an...
- This is a firm-fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), which is part of the U.S. Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC, a for-profit limited liability company. The contract is for the procurement of 6,6 D2-glucose 72.9 mg/ml (30 ml) vials, which are likely being used to support metabolic research studies conducted by NICHD. The contract has a ceiling value of $12,371.12 and a period of...
- This federal contract award was made by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The $173,631.31 firm fixed-price purchase order was awarded on September 22, 2016, with a completion date of September 21, 2017. The contract is for the provision of a drug necessary for use in the NCATS II...
- Veterans Integrated Service Network 23 issued a $21,672.80 delivery order to Pine Pharmaceuticals LLC on October 1, 2025, for 503B compounding pharmaceuticals with a ceiling value of $21,672.80 and ultimate completion date of March 31, 2026. Place of performance is Tonawanda, NY. Pine Pharmaceuticals is an FDA-registered 503B outsourcing facility specializing in pharmaceutical compounding and repackaging for federal agencies, with over 37 years of operational history. This delivery order is...
- This is a federal contract award from the National Institutes of Health (NIH) Clinical Center to Ipharmasupports LLC, a small business subchapter S corporation based in Denver, Colorado. The contract is for the provision of 1-F-DOPA synthesis sets, with a ceiling value of $17,212.70. The contract type is a Blanket Purchase Agreement (BPA) Call, with a firm fixed price pricing structure. The contract was awarded on February 27, 2019, with a completion date of February 27, 2020. Ipharmasupports...
- This is a $76,935.40 firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences, a civilian agency within the U.S. government. The contract was set aside for small businesses and awarded to Pion Inc., a manufacturer of scientific instruments and provider of testing services related to pharmaceutical R&D. Based on Pion's previous federal contracts, the award likely involves the delivery of PAMPA assay products, dissolution and permeability testing...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) awarded a $39,000 firm-fixed-price purchase order to Cambridge Isotope Laboratories, Inc. (CIL) for the delivery of deuterium oxide, D-glucose, glycerol, and other labeled compounds in support of biomedical research programs. CIL, a manufacturer of stable isotopes and isotopically labeled compounds, has provided similar labeled materials to NIH institutes like the...
- <p>The National Institute of Dental and Craniofacial Research issued a purchase order to Chembind LLC for $14,860.00 on September 3, 2020. The order procures undecaprenyl phosphate (UNDP) 50mg as a firm fixed-price commercial item. Work is performed in Atlanta, Georgia, with an ultimate completion date of September 11, 2020.</p>
- This is a firm fixed-price contract awarded by the National Institutes of Health (NIH) Clinical Center to Ipharmasupports LLC, a small business subchapter S corporation based in Denver, Colorado. The contract, valued at $14,050.00, is for the provision of F-DOPA synthesis disposable cassettes. The contract was set aside for small businesses. Ipharmasupports LLC is a vendor that specializes in providing advanced scientific and technical services, including specialized radiosynthesis and...
- 75N94024D00003Indefinite Delivery Contract
- 75N94024D00003-75N98026F00001Delivery Order
The National Institutes of Health issued a $39,278.50 delivery order to Pine Pharmaceuticals LLC on April 21, 2026, under a total small business set-aside for oral stable isotope-deuterium oxide, with final delivery by June 1, 2026. Pine Pharmaceuticals is a small business pharmaceutical compounding and manufacturing firm. Place of performance is Tonawanda, NY. The order ceiling is $39,278.50 under firm fixed-price terms, with ultimate completion scheduled for October 30, 2026. Billing is in one lump sum. Pine Pharmaceuticals specializes in metabolic isotope production and 503B compounding services for federal biomedical research and clinical programs across multiple HHS agencies and the Department of Veterans Affairs.
Generated 7/2/26, 1:51 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $39.3k | 4/20/26 |